Human Abuse Liability study of Mallinckrodt's Oxycodone/paracetamol combination in recreational opioid abusers.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2014
Price : $35 *
At a glance
- Drugs Oxycodone/paracetamol (Primary)
- Indications Pain
- Focus Pharmacodynamics
- 12 Sep 2013 Results were presented at PAINWeek 2013, and in a Mallinckrodt media release.
- 12 Sep 2013 New trial record
- 04 Sep 2013 Primary endpoint 'Psychological-measures' has been met.